Lymphatic Disorders Clinical Trial
Official title:
Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders, Including Lymphedema, Lymphangioma, Lymphangioleiomyomatosis, Plastic Bronchitis, Lymphadenopathy Caused by Rheumatoid Arthritis, Etc.
This is an open-label whole-body PET/CT study for investigating the value of 68Ga NEB PET imaging in the diagnosis and evaluation of lymphatic disorders including lymphedema, lymphangioma, lymphangioleiomyomatosis, plastic bronchitis, lymphadenopathy caused by rheumatoid arthritis, etc.
No fasting, hydration or other specific preparation was requested on the day of imaging.
Patients for lymphatic drainage disorders imaging underwent whole-body PET/CT acquisitions
20-40 min after subcutaneously injected into first and second interdigital spaces of both
feet or hands of 74-111 MBq (2-3 mCi) 68Ga-NEB with each bed position lasted for 2 min.
A MIM workstation was used for post-processing. The visual method was used to evaluate the
lymphatic system, including the morphology and the distribution of the lymphatic system.
Semiquantitative methods were applied for image analysis.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT00833599 -
Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders
|